Validea Detailed Fundamental Analysis

Humana (HUM) is Validea's top-rated stock among its 22 guru strategies, specifically under Meb Faber's Shareholder Yield Investor model, where it scored 70%. Although this model emphasizes shareholder cash returns via dividends, buybacks, and debt paydown, HUM's score is below the 80% threshold for typical strategy interest, and critically, the company failed the Net Payout Yield and Shareholder Yield criteria despite passing on valuation, quality, and relative strength.

Analysis

Humana Inc. (HUM) is presented with a mixed fundamental profile according to Validea's analysis using Meb Faber's Shareholder Yield Investor model. While HUM ranks as the highest-rated stock among 22 strategies, its specific score of 70% falls below the 80% threshold that typically signals genuine interest from the model. A significant contradiction exists within the report: despite the model's focus on cash returns to shareholders, HUM explicitly fails the 'Net Payout Yield' and 'Shareholder Yield' criteria. The stock's positive attributes, which allowed it to pass tests for 'Quality and Debt', 'Valuation', and 'Relative Strength', are overshadowed by its failure to meet the primary objective of the very strategy that ranks it highly. This suggests that while HUM may possess favorable underlying fundamentals and valuation, it does not currently exemplify the characteristics of a top-tier shareholder yield company.

Key Decisions for Investors

• Investors should view the 'highest rating' with caution, as Humana fails the core capital return metrics of the specific model used for the evaluation, indicating a mismatch between the stock's profile and the strategy's thesis.
• The passing scores on 'Quality and Debt' and 'Valuation' may warrant further due diligence for a value or quality-focused investment case, but not for an investment strategy primarily targeting shareholder yield.
• Monitor for future announcements from Humana regarding changes to its dividend, share buyback programs, or debt reduction plans, as improvements in these areas would be required to validate the shareholder yield thesis for the stock.